Philips Respironics has notified suppliers that it plans to outsource manufacturing operations from its Pennsylvania facilities in Murrysville and New Kensington to Thailand. That’s according to ...

Philips Respironics is also addressing new non-safety issues in these updates.” Philips said that the ventilators should not be used until the devices’ software has been updated. The company also ...

Philips Respironics plans to close its registration portal at the end of December 2024, with the goal of completing its repair and replacement program in Canada by the end of June 2025.

Pricing And Productivity More Than Offset By Respironics Settlement. Philips. For the first quarter, reported sales growth was negative 1% while comparable sales growth was 2.4%.

TO BE CLEAR, WITH REPAIR DEVICES, ... Philips Respironics leaving some western Pa. sites in move that will impact hundreds of jobs. Updated: 10:21 PM EDT Jun 18, 2024 ...

Medical device maker Philips announced a nearly $1.1 billion personal injury settlement over some of its CPAP, ventilators and BiPAP machines that were at the heart of a massive recall in 2021.

For the first quarter of 2024, Philips reported 4.1 billion euros in sales, or about $4.4 billion, for growth of 2.4%. The $1.1 billion settlement provision, or about 982 million euros, wiped out ...

Philips and Philips Respironics will pay $1.1 billion to settle personal injury litigation in the United States in connection to the issues over its sleep therapy devices.

Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 billion Respironics litigation settlement reached in the US ...

Philips reaches $479 million settlement over CPAP machine recall 00:23. Dutch medical device maker Philips said Monday it had reached a $1.1 billion deal in the United States to settle lawsuits ...

Philips settles $1.1 billion in Respironics ventilator recall lawsuit. Updates on Philips' Q1 performance and 2024 guidance. PHG shares surge 36.9% in premarket trading.

Roy Jakobs, CEO of Royal Philips: “We started the year in line with our plan, with order intake growth outside China turning positive and strong margin improvement. Supported by key innovation ...